Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-16

FDA Approved: FIDAXOMICIN — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Teva's generic fidaxomicin for the treatment of Clostridioides difficile infection under an ANDA approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fidaxomicin (fidaxomicin)

Snippet

ORIG AP for FIDAXOMICIN (FIDAXOMICIN)